Figure 1
Figure 1. Study populations by randomized treatment group in the double-blind phase. BM indicates bone marrow; LEN, lenalidomide; and Int, Intermediate.

Study populations by randomized treatment group in the double-blind phase. BM indicates bone marrow; LEN, lenalidomide; and Int, Intermediate.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal